Catalent has announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri. The project will see the addition of two new analytical development laboratories to support the growing demands of assay development for both traditional biologic and advanced biologic modality programs.   The first of the two new laboratories will cover approximately 3,500 square feet and will be completed by the end of October 2022, with...